David Palma, Radiation Oncologist at London Health Sciences Centre and Professor at Western University, shared a post on X about a paper by Vijay Maruti Patil et al. published in the Journal of Clinical Oncology:
“H+N oncologists: anyone seeing high rates of severe skin toxicity with RT + concurrent docetaxel (15 mg/m2)?
Some of the skin reactions are the worst I’ve seen. Wondering if this is a cetuximab moment.”
Title: Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
Authors: Vijay Maruti Patil, Vanita Noronha, Nandini Menon, Ajay Singh, Sarbani Ghosh-Laskar, Ashwini Budrukkar, Atanu Bhattacharjee, Monali Swain, Vijayalakshmi Mathrudev, Kavita Nawale, Arun Balaji, Zoya Peelay, Mitali Alone, Shruti Pathak, Abhishek Mahajan, Suman Kumar, Nilendu Purandare, Archi Agarwal, Ameya Puranik, Shantanu Pendse, Monica Reddy Yallala, Harsh Sahu, Venkatesh Kapu, Sayak Dey, Jatin Choudhary, Madala Ravi Krishna, Alok Shetty, Naveen Karuvandan, Rahul Ravind, Rahul Rai, Kunal Jobanputra, Pankaj Chaturvedi, Prathamesh S. Pai, Devendra Chaukar, Sudhir Nair, Shivakumar Thiagarajan, Kumar Prabhash
You can read the Full Article on the Journal of Clinical Oncology.
More posts featuring David Palma.